These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26224663)

  • 1. Impact of the serum ferritin concentration in liver transplantation.
    Wakiya T; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Hirata Y; Hakamada K; Yasuda Y; Mizuta K
    Liver Transpl; 2015 Nov; 21(11):1419-27. PubMed ID: 26224663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival.
    Weismüller TJ; Kirchner GI; Scherer MN; Negm AA; Schnitzbauer AA; Lehner F; Klempnauer J; Schlitt HJ; Manns MP; Strassburg CP
    Hepatology; 2011 Dec; 54(6):2114-24. PubMed ID: 21898488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictors of the results of kidney transplantation from living-related donors].
    Goryainov VA; Kaabak MM; Babenko NN; Morozova MM; Platova EN; Dymova OV; Panin VV
    Khirurgiia (Mosk); 2015; (4):43-47. PubMed ID: 26081186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High preoperative bilirubin values protect against reperfusion injury after live donor liver transplantation.
    Spetzler VN; Goldaracena N; Kaths JM; Marquez M; Selzner N; Cattral MS; Greig PD; Lilly L; McGilvray ID; Levy GA; Ghanekar A; Renner EL; Grant DR; Selzner M
    Transpl Int; 2015 Nov; 28(11):1317-25. PubMed ID: 26147741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients.
    Döring M; Cabanillas Stanchi KM; Feucht J; Queudeville M; Teltschik HM; Lang P; Feuchtinger T; Handgretinger R; Müller I
    Ann Hematol; 2016 Jan; 95(2):311-23. PubMed ID: 26611853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of post-reperfusion syndrome in living donor liver transplantation.
    Chung IS; Kim HY; Shin YH; Ko JS; Gwak MS; Sim WS; Kim GS; Lee SK
    Clin Transplant; 2012; 26(4):539-43. PubMed ID: 22168355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation.
    Killackey MT; Gondolesi GE; Liu LU; Paramesh AS; Thung SN; Suriawinata A; Nguyen E; Roayaie S; Schwartz ME; Emre S; Schiano TD
    Transplant Proc; 2008 Jun; 40(5):1504-10. PubMed ID: 18589139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischaemic preconditioning of the graft in adult living related right lobe liver transplantation: impact on ischaemia-reperfusion injury and clinical relevance.
    Andreani P; Hoti E; de la Serna S; degli Esposti D; Sebagh M; Lemoine A; Ichai P; Saliba F; Castaing D; Azoulay D
    HPB (Oxford); 2010 Sep; 12(7):439-46. PubMed ID: 20815852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Rifaximin Therapy on Ischemia/Reperfusion Injury in Liver Transplantation: A Propensity Score-Matched Analysis.
    Ito T; Nakamura K; Kageyama S; Korayem IM; Hirao H; Kadono K; Aziz J; Younan S; DiNorcia J; Agopian VG; Yersiz H; Farmer DG; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
    Liver Transpl; 2019 Dec; 25(12):1778-1789. PubMed ID: 31509643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dexmedetomidine on hepatic ischemia-reperfusion injury in the setting of adult living donor liver transplantation.
    Fayed NA; Sayed EI; Saleh SM; Ehsan NA; Elfert AY
    Clin Transplant; 2016 Apr; 30(4):470-82. PubMed ID: 26856320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients.
    Bhat M; Ghali P; Rollet-Kurhajec KC; Bhat A; Wong P; Deschenes M; Sebastiani G
    Liver Transpl; 2015 Nov; 21(11):1383-94. PubMed ID: 26194602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of true-positive and false-positive pretransplantation lymphocytotoxic crossmatch in primary liver allograft outcomes.
    Shin M; Moon HH; Kim JM; Park JB; Kwon CH; Kim SJ; Lee SK; Joh JW
    Transplantation; 2013 Jun; 95(11):1410-7. PubMed ID: 23542470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis, Incidence, Predictors and Management of Postreperfusion Syndrome in Pediatric Deceased Donor Liver Transplantation: A Single-Center Study.
    Zhang L; Tian M; Xue F; Zhu Z
    Ann Transplant; 2018 May; 23():334-344. PubMed ID: 29773782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors for new-onset diabetes in living-donor liver transplant recipients.
    Honda M; Asonuma K; Hayashida S; Suda H; Ohya Y; Lee KJ; Yamamoto H; Takeichi T; Inomata Y
    Clin Transplant; 2013; 27(3):426-35. PubMed ID: 23464510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
    Chiu KW; Chen YS; de Villa VH; Wang CC; Eng HL; Wang SH; Liu PP; Jawan B; Huang TL; Cheng YF; Chen CL
    Hepatogastroenterology; 2005; 52(66):1825-7. PubMed ID: 16334785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 6 at reperfusion: A potent predictor of hepatic and extrahepatic early complications after liver transplantation.
    Faitot F; Besch C; Lebas B; Addeo P; Ellero B; Woehl-Jaegle ML; Namer IJ; Bachellier P; Freys G
    Clin Transplant; 2018 Sep; 32(9):e13357. PubMed ID: 30044000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the best immunosuppression in living donor liver transplantation?
    Ringe B; Moritz M; Zeldin G; Soriano H
    Transplant Proc; 2005 Jun; 37(5):2169-71. PubMed ID: 15964369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of some immunological and non-immunological factors on early and distant function of transplanted kidney].
    Sierńko J
    Ann Acad Med Stetin; 2004; 50(1):53-67. PubMed ID: 16871744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.
    Pirenne J; Van Gelder F; Coosemans W; Aerts R; Gunson B; Koshiba T; Fourneau I; Mirza D; Van Steenbergen W; Fevery J; Nevens F; McMaster P
    Liver Transpl; 2001 Jun; 7(6):540-5. PubMed ID: 11443584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrosteatotic and nonmacrosteatotic grafts respond differently to intermittent hepatic inflow occlusion: Comparison of recipient survival.
    Han S; Choi GS; Kim JM; Kwon JH; Park HW; Kim G; Kwon CH; Gwak MS; Ko JS; Joh JW
    Liver Transpl; 2015 May; 21(5):644-51. PubMed ID: 25690881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.